Lu Lu Tong (Sweetgum Fruit)

Chinese Herb Actions

Chinese Herb Dosage

• What is the typical dosage of Lu Lu Tong?

  Reference materia medica place Lu Lu Tong at roughly 3–9 grams per day in decoction; the Sacred Lotus records 4.5–9 g from one cited authority and 3–9 g from the other. It is a conventional, non-toxic herb used in ordinary decoction quantities, with no restricted or minute-dose handling.

  • The material is the whole infructescence — the dried, spiky, many-chambered compound fruiting head, which is why the herb is sometimes described as an “infructescence” rather than a single fruit in the research literature.
  • Professional supervision — herbs are prescribed within a formula by a qualified practitioner; the range above is reference literature, not a prescription.

  Source: Sacred Lotus recorded dosage (4.5–9 g, Bensky; 3–9 g, Chen); PMID 12579820 (chemical composition of fructus Liquidambaris / lulutong — material identity); materia medica consensus. Reference range for practitioners and students.

Chinese Herb Contraindications & Cautions

• Are there cautions for Lu Lu Tong? Is it safe?

  Lu Lu Tong is a low-risk herb — the Sacred Lotus records no toxicity for it — but it is contraindicated in pregnancy and in heavy menstrual bleeding, both of which follow directly from its blood-moving action.

  • Pregnancy — do not use. Blood-invigorating herbs are contraindicated in pregnancy as a class; the Sacred Lotus record states this without qualification for Lu Lu Tong.
  • Heavy menstrual bleeding (hypermenorrhea) — do not use. A herb that moves blood is inappropriate where bleeding is already excessive.
  • Blood or yin deficiency — as with other moving-and-dispersing herbs, caution is reasonable where there is marked deficiency, since the herb disperses rather than nourishes.
  • Reported lactation caution — see the research section: a network-pharmacology finding raises a question about the herb’s traditional use for insufficient lactation. It is not a safety alert, but it is a reason not to assume that indication uncritically.

  Source: Sacred Lotus cautions record (pregnancy; hypermenorrhea) and toxicity record; materia medica consensus on blood-invigorating herbs. Reference information only — not medical advice.

Chinese Herb Toxicity & Overdose

• None Noted

Herb-Drug Interactions

• Does Lu Lu Tong interact with medications?

  No clinical herb–drug interaction data are documented for Lu Lu Tong, and none are asserted here. The Sacred Lotus record notes no interactions, and the published research is preclinical rather than pharmacokinetic.

  • Theoretical area only — as a blood-invigorating herb, the customary practitioner caution around anticoagulant and antiplatelet medication applies as a category-level precaution. No interaction has been demonstrated for this herb specifically. (Flagged for practitioner confirmation.)

  Source: Sacred Lotus records; materia medica consensus on blood-invigorating herbs. Precautionary reference, not a documented interaction claim.

Western / Biomedical Research

Chinese Herb Clinical Studies & Research

Provided as research context — a summary of published biomedical study, not a therapeutic or medical claim.

• Is there modern research on Lu Lu Tong (Fructus Liquidambaris)?

  Yes — a modest but coherent body of work, concentrated on the triterpenoids and volatile constituents of the infructescence, with anti-inflammatory/anti-arthritic research being the strand that maps most directly onto the herb’s traditional use for joint pain. Early compositional work characterised the constituents of fructus Liquidambaris under its Chinese name lulutong; oleanane-type triterpenoids with inhibitory activity against the NFAT transcription factor were reported from Liquidambar formosana as far back as 2004.

  • Rheumatoid arthritis (preclinical) — in adjuvant-induced arthritis rats, a petroleum-ether extract of the fruit reduced paw swelling, joint and bone destruction, synovial inflammation and cartilage erosion, lowered serum IL-1β and TNF-α, and reduced NLRP3, IL-1β and caspase-1 p20 expression in synovial tissue. Network pharmacology and docking identified myrtenal and β-caryophyllene oxide as the principal actives, and both suppressed NLRP3 inflammasome components in human rheumatoid-arthritis synovial cells. This is the closest modern correlate to the traditional joint-pain indication, and it remains animal and cell work.
  • Triterpenoid chemistry and oncology (preclinical) — thirteen triterpenoids have been isolated from Liquidambaris Fructus, six of them for the first time; separate work reports apoptosis induction in liver cancer cells via PI3K-AKT-related signalling, and pharmacokinetic/mechanistic analysis of absorbed constituents in a hepatocellular carcinoma model. All preclinical.
  • A finding that questions a traditional use — the same triterpenoid target-identification study concluded that its predicted targets included ErbB4, and noted that the traditional application of Liquidambaris Fructus for insufficient lactation “should be reassessed systematically because it might suppress rather than promote lactation by inhibiting the activity of ErbB4.” This is a computational and in-vitro inference rather than a clinical finding, but it is a rare instance of modern work directly challenging a classical indication, and it is reported here rather than omitted.

  Human clinical-trial evidence for Lu Lu Tong is essentially absent. Everything above is preclinical and is presented as research context, not as evidence of therapeutic effect.

  Sources: PMID 12579820 (chemical composition of fructus Liquidambaris / lulutong); PMID 14993816, DOI 10.1248/bpb.27.426 (oleanane triterpenoids with NFAT-inhibitory activity from Liquidambar formosana); PMID 34583676, DOI 10.1186/s12906-021-03410-2, PMC 8480017 (myrtenal and β-caryophyllene oxide; NLRP3 inflammasome; adjuvant-induced arthritis); PMID 33246450, DOI 10.1186/s12906-020-03143-8, PMC 7694930 (triterpenoid target identification; the ErbB4/lactation caveat); PMID 31911265, DOI 10.1016/j.phytochem.2019.112228 (triterpenoid-induced apoptosis via PI3K-AKT); PMID 36110518, DOI 10.3389/fphar.2022.999935 (absorbed constituents and mechanism in hepatocellular carcinoma). Research context, not a therapeutic claim.

Chinese Herb Notes

• What is the difference between Lu Lu Tong, Feng Xiang Zhi and Su He Xiang?

  All three trace back to the sweetgum genus Liquidambar, but they are three different medicinals from two different species and two different plant parts — and only one of them, Lu Lu Tong, is the fruit.

  • Lu Lu Tong — the fruit. The dried infructescence of Liquidambar formosana Hance, recorded in the research literature as Fructus Liquidambaris / Liquidambaris Fructus. This is the entry you are reading: a bitter, neutral, blood-invigorating and channel-opening herb.
  • Feng Xiang Zhi — the resin of the same tree. The resin of Liquidambar formosana is a distinct medicinal material with its own phytochemical literature (pentacyclic triterpenes have been isolated from it, and its constituents studied for anti-angiogenic activity). It is aromatic and resin-based rather than fruit-based, and is traditionally used quite differently — for trauma, sores and pain, in the resin-medicinal family alongside Ru Xiang and Mo Yao. Feng Xiang Zhi does not currently have its own entry in the Sacred Lotus, so we describe it here only to prevent confusion with Lu Lu Tong, and cite it to the published literature rather than to a site record.
  • Su He Xiang — storax, the resin of a different Liquidambar species. Su He Xiang is held in the Sacred Lotus as a separate herb (recorded Latin Styrax Liquidis, “rose maloes resin”), and our own monograph for it already notes that the resin derives botanically from Liquidambar orientalis Mill. rather than from the genus Styrax. It is sweet, acrid, warm and intensely aromatic, and belongs to an entirely different functional class — the orifice-opening aromatics, as in Su He Xiang Wan. It is not interchangeable with either of the above.
  • Why the confusion matters — the shared genus and the shared English word “sweetgum/storax” make these three easy to conflate in sourcing and in translation, but a fruit, a domestic resin and an imported aromatic resin behave as three unrelated medicinals in practice.

  Note on the Latin name: the Sacred Lotus records this herb as Fructus Liquidambaris Taiwaniae, while the Chinese Pharmacopoeia and the research literature consistently use Fructus Liquidambaris / Liquidambaris Fructus, derived from Liquidambar formosana Hance. The species epithet “Taiwaniae” does not appear in the pharmacopoeial or research usage we could verify (Taiwania is a separate conifer genus). The material is the same; the identity field is left unchanged and flagged for owner review.

  Source: Sacred Lotus herb records for Lu Lu Tong and Su He Xiang (and the absence of any Feng Xiang Zhi record); PMID 12579820 (fructus Liquidambaris / lulutong); PMID 33246450, DOI 10.1186/s12906-020-03143-8 (Liquidambaris Fructus as the infructescence of Liquidambar formosana Hance); PMID 21605635, DOI 10.1016/j.fitote.2011.05.003 (pentacyclic triterpenes from the resin of Liquidambar formosana); PMID 33556839, DOI 10.1016/j.phytochem.2021.112676 (resin triterpenes, anti-angiogenic); materia medica consensus on resin medicinals.